By proceeding, you agree to our Terms of Use and Privacy Policy.
BioDuro-Sundia is a global provider of contract research, development and manufacturing outsourcing solutions.
11-12 October 2022
The Formulation & Drug Delivery Congress will discuss the state of the industry, looking at new strategies for optimizing biologic formulations such as antibodies, proteins and vaccines, as well as highlighting key updates in amorphous solid dispersi
Event Ended
USA
Paid
San Diego
25-28 October 2022
The 5th Annual Targeted Protein Degradation Summit is the world leading industry-dedicated conference that spans the full drug development pipeline from discovery through to the clinic addressing key challenges to make this exciting new modality a th
Boston
27-28 June 2023
The next generation of drug and therapeutic delivery is here…Attend and connect with 160+ senior drug development innovators this May and uncover industry’s latest formulation and delivery technologies for improving drug product performance and
Hybrid
Princeton
25-25 September 2023
The coronavirus pandemic ignited interest in learning more about immune responses to infections, their downstream effects, and how they can be modulated. It also gave rise to increased awareness of the role of immunity in diseases like cancer, neurod
Washington, DC
There has been growing interest in targeting kinases such as JAK, TYK, IRAK, SIK, CDK, MEK, ERK, RTK, PLK, PI3K, ALK, MAPK, GSK, LRRK, and more for their role in neurodegeneration, inflammation, cancer, autoimmune, and other disorders. However, targe
26-27 September 2023
Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying nove
While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s c
Cambridge Healthtech Institute's GPCR-Based Drug Discovery conference is now in its 18th year. G protein-coupled receptors (GPCRs), because of their central role in so many cellular processes, are still among the largest class of molecules modulated
Small molecule-based therapeutic options against traditionally hard-to-drug intracellular oncology targets (like KRAS) are being discovered at a more rapid pace and a few have even reached the market in the past few years. Not only do small molecules
As the industry increasingly shifts its attention to biologics, more attention is being paid to the prospect of developing biotherapeutics against membrane-bound targets. For these large target classes, biologics offer improved selectivity, an altern
A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are
Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets conference focuses on therapeutic candidates in clinical or earlier stage development that modulate molecules or cellular processes involved in neurodegenerative diseases, especial
27-27 September 2023
The 14th Annual Arizona Technology Summit will be held on September 27th, 2023 at the Phoenix Convention Center (100 N 3rd Street, Phoenix, AZ 85004) from 8am-4pm. This B2B conference is targeted for the Technology and Security community. Attendees c
PHOENIX
27-28 September 2023
Cambridge Healthtech Institute’s annual Lead Generation Strategies conference illuminates the latest approaches used by medicinal, biophysical and computational chemists to discover and develop small molecules (and now slightly larger molecules that
Fibrosis can be viewed as the end-stage of chronic inflammation. Fibrosis and inflammation are related to the immune system gone awry and both underlie many conditions related to aging and therefore are increasing in prevalence in the US. Cambridge H
Transcription factors are proteins with DNA-binding domains that are involved in gene transcription. They are key cell regulators and alterations in their structure, binding, or activity are often found associated with many abnormalities in cellular
02-03 October 2023
Formulation & Delivery US 2023 features 2 outstanding programmes, bringing together key opinion leaders under one roof. The events provide a unique networking platform which consists of vital discussion topics in: Formulation & Drug Delivery and Inha
Free
Over 300 attendees representing internationally renowned academic organisations & research institutes as well as global pharmaceutical organisations, leading biotech companiesOver 20 case studies, presentations, panel discussions focused on the k